Home / Digestive tract and metabolism / Saxagliptin
ATC A10BH03 · Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors
Saxagliptin shortage
As of 2 Nov 2026, Saxagliptin has a reported shortage in 2 of the 16 countries we track (Canada, Norway), covering 2 products from 2 companies.
Countries2/16
Products2packs or presentations
Companies20 listed
Short since8 Dec 202511 months ago
Earliest return8 Jan 2027company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorway1 product shortSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
CanadaNorway
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group A10BH · Dipeptidyl Peptidase 4 (Dpp-4) InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-SAXAGLIPTIN (30 BLS) | APOTEX INC | 27 Oct 2026 | 8 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| NO | Onglyza 5 mg tablett, filmdrasjert, 98 stk blisterpakning | Orifarm As | 8 Dec 2025 | 1 Feb 2027 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.